Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

ETR/MED stock hub

ETR/MED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/MEDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

168.2M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/MED

In the news

Latest news · ETR/MED

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E4.6

P25 12.3P50 15.7P75 20.2

Trailing P/E6.1

P25 16.4P50 20.9P75 30.4

ROE12.4

P25 -6.7P50 8.5P75 17.2

ROIC8.5

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/MED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

EUR

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	7,677
Employees Change	-2,795%
Employees Change Percent	-26.69
Enterprise value	EUR 474.6M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	DE0006595101
Last refreshed	2026-05-10
Market cap	EUR 168.2M
Price	EUR 3.54
Price currency	EUR
Rev Per Employee	105,572.55x
Sector	Healthcare
Sic	8093
Symbol	etr/MED
Website	https://www.mediclin.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	17.35%
EV Earnings	16.27x
EV/EBIT	7.37x
EV/EBITDA	4.06x
EV/FCF	9.32x
EV/Sales	0.59x
FCF yield	30.29%
Forward P/E	4.6x
P/B ratio	0.66x
P/E ratio	6.12x
P/S ratio	0.21x
PE Ratio10 Y	62.9x
PE Ratio3 Y	6.2x
PE Ratio5 Y	18.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.93%
EBITDA Margin	10.7%
FCF margin	6.28%
Gross margin	21.18%
Gross Profit	EUR 171.6M
Gross Profit Growth	15.82%
Gross Profit Growth Q	14.69%
Gross Profit Growth3 Y	10.16%
Gross Profit Growth5 Y	11.11%
Net Income	EUR 29.2M
Net Income Growth	11.9%
Net Income Growth Years	2%
Net Income Growth3 Y	60.73%
Pretax Margin	4.93%
Profit Margin	3.6%
Profit Per Employee	EUR 3,801
Profitable Years	2
ROA	4.63
Roa5y	2.33
ROCE	9.61
ROE	12.39
Roe5y	4.67
ROIC	8.51
Roic5y	4.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.6%
Cagr15y	-0.88%
Cagr1y	22.08%
Cagr20y	-0.86%
Cagr3y	7.11%
Cagr5y	-3.55%
Div CAGR10	-2.21%
Div CAGR3	0%
Div CAGR5	-4.36%
EPS Growth	5.9
EPS Growth Years	2
EPS Growth3 Y	57.58
FCF Growth	24.23%
FCF Growth Q	-43.3%
FCF Growth3 Y	67.36%
FCF Growth5 Y	-12.99%
OCF Growth	19.52%
OCF Growth Q	-34.44%
OCF Growth10 Y	11.62%
OCF Growth3 Y	35.55%
OCF Growth5 Y	-4.32%
Revenue Growth	6.77x
Revenue Growth Q	3.11x
Revenue Growth Quarters	3x
Revenue Growth Years	5x
Revenue Growth3 Y	3.87x
Revenue Growth5 Y	4.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.94
Assets	EUR 835.9M
Cash	EUR 78.3M
Current Assets	EUR 290.5M
Current Liabilities	EUR 167.1M
Debt	EUR 384.1M
Debt EBITDA	EUR 3.29
Debt Equity	EUR 1.52
Debt FCF	EUR 7.54
Equity	EUR 253.2M
Interest Coverage	3.2
Liabilities	EUR 582.7M
Long Term Assets	EUR 545.4M
Long Term Liabilities	EUR 415.7M
Net Cash	EUR -305.8M
Net Cash By Market Cap	EUR -182
Net Debt EBITDA	EUR 3.53
Net Debt Equity	EUR 1.21
Net Debt FCF	EUR 6
Tangible Book Value	EUR 235.8M
Tangible Book Value Per Share	EUR 4.68
WACC	4.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.74
Inventory Turnover	96.54
Net Working Capital	EUR 73.7M
Quick ratio	1.09
Working Capital	EUR 123.5M
Working Capital Turnover	EUR 6.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-6.13%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 0.04
Dividend Years	2
Dividend Yield	1.13%
Ex Div Date	2026-05-29
Last Dividend	EUR 0.04
Payout Ratio	13.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-30.7%
1Y total return	22.06%
200-day SMA	3.45
3Y total return	22.89%
50-day SMA	3.55
50-day SMA vs 200-day SMA	50over200
5Y total return	-16.55%
All Time High	15.18
All Time High Change	-76.68%
All Time High Date	2001-01-02
All Time Low	0.98
All Time Low Change	261.22%
All Time Low Date	2002-10-07
ATR	0.15
Beta	0.39
Beta1y	0.44
Beta2y	0.35
Ch YTD	-4.32
High	3.6
High52	4.06
High52 Date	2026-01-23
High52ch	-12.81%
Low	3.54
Low52	2.86
Low52 Date	2025-07-29
Low52ch	23.78%
Ma50ch	-0.28%
Price vs 200-day SMA	2.58%
RSI	52.53
RSI Monthly	57.36
RSI Weekly	49.98
Sharpe ratio	0.64x
Sortino ratio	1.15
Total Return	-5%
Tr YTD	-4.32
Tr15y	-12.43%
Tr1m	0.57%
Tr3m	-8.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 64.3M
Operating Income Growth	24.47
Operating Income Growth Q	77.94
Operating Income Growth3 Y	78.25
Operating margin	7.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,438,997%
Net Borrowing	-77,350,179
Shares Institutions	36.34%
Shares Out	47,500,000
Shares Qo Q	6.13%
Shares Yo Y	6.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 50.9M
Average Volume	10,064.2x
Bv Per Share	5.01
CAPEX	EUR -45.5M
Ch10y	-32.81
Ch15y	-16.11
Ch1m	0.57
Ch1y	20.41
Ch20y	-22.2
Ch3m	-8.29
Ch3y	21.23
Ch5y	-17.67
Ch6m	-0.56
Change	0%
Change From Open	-0.56
Close	3.54
Days Gap	0.56
Depreciation Amortization	22,440,399
Dollar Volume	44,696
Earnings Date	2026-05-04
EBIT	EUR 64.3M
EBITDA	EUR 86.7M
EPS	EUR 0.58
F Score	7
FCF	EUR 50.9M
FCF EV Yield	10.73x
FCF Per Share	EUR 1.07
Financing CF	-98,942,240
Fiscal Year End	December
Founded	1,994
Goodwill	8,835,610
Graham Number	8.0761
Graham Upside	128.1
Income Tax	EUR 10.4M
Investing CF	-23,664,472
Is Primary Listing	1
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Lynch Fair Value	EUR 14.47
Lynch Upside	308.8
Ma150	3.6
Ma150ch	-1.69%
Ma20	3.46
Ma20ch	2.25%
Net CF	-26,201,024
Next Earnings Date	2026-07-30
Open	3.56
P FCF Ratio	3.3
P OCF Ratio	1.74
Payment Date	2026-06-02
Position In Range	0
Ppne	498,986,108
Price Date	2026-05-08
Price EBITDA	EUR 1.94
Ptbv Ratio	0.71
Relative Volume	1.27x
Revenue	810,480,476x
Tax By Revenue	1.28x
Tax Rate	25.99%
Tr20y	-15.91%
Tr6m	-0.56%
Volume	12,626

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/MED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$0.04 annual per share

Payout ratio

+13.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-4.4%

0 consecutive years of growth

Total shareholder yield

-5.0%

Next ex-dividend date: 2026-05-29

Performance

ETR/MED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/MED?

Insider, institutional, and short-interest positioning.

Institutional ownership

+36.3%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+6.1%

Negative means the company is buying back shares.

Technical

ETR/MED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.5

Neutral momentum band

Price vs 200-day MA

+2.6%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/MED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/MED stock rating?

etr/MED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/MED analysis?

The full report lives at /stocks/etr/MED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/MED?

The latest report frames etr/MED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/MED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.